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syndrome: a case report and review of the literature
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Discussion
❑ Table 1 illustrates the clinical characteristics of 9 various cases of cryoglobulinemia described in the literature,
including our own case.1–4

❑ Cryoglobulinemic vasculitis is a life-threatening disorder caused by immune complex mediated end-organ damage
from precipitation and vascular occlusion of large concentrations of cryoglobulins.
❑ Cryoglobulins are immunoglobulins that precipitate at cold temperatures (below 37 ˚C) and redissolve with
warming.1
❑ Cryoglobulinemia indicates the presence of serum immunoglobulins and are clinically classified into three types:
❑ Type I – monoclonal cryoglobulins (usually IgG or IgM)
▪ Develop from gammopathies with predominant protein secretion, such as Waldenström macroglobulinemia,
multiple myeloma, chronic lymphocytic leukemia, and monoclonal gammopathy of undetermined
significance (MGUS)1,2
❑ Type II – a mix of monoclonal IgM cryoglobulins with rheumatoid factor (RF) activity and polyclonal IgG
▪ Caused by infections with Hepatitis C virus (~90%), HIV, HBV, connective tissue diseases, and
lymphoproliferative disorders1–3
❑ Type III – a mix of polyclonal IgM cryoglobulins with RF activity and polyclonal IgG1
▪ Associated with autoimmune disorders such as Sjögren’s syndrome and systemic lupus erythematosus (SLE)1–3
❑ Essential mixed cryoglobulinemia refers to ~10% of patients with cryoglobulinemia with no identifiable cause.1

❑ The average age of patients affected with cryoglobulinemia = 54.8 years old
▪ This is similar to the overall mean age of 45-60 years old at presentation among cryoglobulinemia cases
previously described in the literature.2
❑ The gender distribution in our review was approximately 2:1 female:male, which is similar to the ratio of
approximately 3:1 female:male previously described in the literature.2
❑ Approximately 44.5% of cases we reviewed involved previously healthy patients prior to diagnosis with
cryoglobulinemia.
❑ Approximately 33% of patients had infectious etiologies, with 22% attributed to HCV and 11% attributed to HIV.
❑ Roughly 66% of patients we reviewed received corticosteroids and/or B cell depletion therapy with Rituximab,
making these the two most popular treatments administered. This supports evidence from the literature that
showed Rituximab given in combination with corticosteroids achieved superior clinical, renal, and immunologic
responses compared to corticosteroids alone.4
❑ About 33% of patients received plasma exchange therapy due to severity of disease.
❑ Finally, is reassuring to note that all patients made a recovery, with 88.9% making full recovery and only 11.1%
relapsing.

Purpose
❑ In this report, we present a unique case of cryoglobulinemic vasculitis in a 48-year-old Caucasian male with
Sjögren’s syndrome.
❑ We subsequently review 9 cases of cryoglobulinemia found in the literature and provide a valuable perspective to this
condition.
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Background

➢ Although cryoglobulinemia has been commonly attributed to infectious etiologies such as
Hepatitis C virus, our case report and brief literature review demonstrate alternative
causes to keep in mind when synthesizing a differential diagnosis.

First Hospital Presentation
(5/2021):

Rheumatology appt #1
(7/2021):

Rheumatology appt #2
(11/2021):

▪ Progressive SOB, LLE edema, RLE
wound, Raynaud phenomenon,
xerostomia, urticarial rash
▪ CT chest/abdomen: Axillary LAD +
spiculated lung lesion
▪ Rheum workup: +ANA, +SSA,
+SSB, low complements,
+cryoglobulins
▪ Plan: Urgent referral to Heme/Onc +
Pulm, smoking cessation
o Ordered dsDNA, Ig levels, CMV

▪ Worsening of RLE wound, continued
LLE edema
▪ Seen by heme/onc & discussed at
tumor board - not c/w malignancy
▪ Exam: LLE non pitting edema,
hard/tender cervical adenopathy, RLE
tender wound with granulation tissue
and surround erythema
▪ Plan: Initiate HCQ and PDN taper
40mg → 20mg
o Ophthalmology consult
o Pulm visit pending

▪ CC hives (dermatology completed punch
biopsy c/w LCV), resolving RLE wound
▪ Not taking HCQ/PDN
▪ Exam: Axillary LAD, left leg non-pitting
edema
▪ Urticarial rash on arms, neck, back,
abdomen + overlying excoriations
▪ Plan: Repeat CT abd/pelvis, Inguinal LN
biopsy with IR, Ophtho – Schirmer and
OSS
o Established care with Tulane pulm –
SABA/Stiolto, chantix
o PFTs: Severe obstruction, moderate ↓
DLCO

➢ Clinicians should be aware of the ever-evolving treatment options for this disease and
carefully choose a tailored regimen that addresses the root cause while managing
potentially life-threatening complications.
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Figure A: Diffuse LLE edema upon admission
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Figure B: Hospital Day 8, purpuric skin lesions, cryoglobulins ordered
Figure C: Hospital Day 11, Petechiae, R hand
Figure D: Hospital Day 11, Necrotizing fasciitis R toes
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Table 1.

Third / Last Hospital Presentation:
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HPI:
48-year-old previously healthy Caucasian male with recently diagnosed seropositive Sjögren’s syndrome (+ANA, +SSA/SSB),
cryoglobulinemia and COPD who presents with painful LLE swelling, worsening SOB, and subjective fevers.
▪ Social: Construction worker w/32-PY smoking history
▪ FamHx: Rectal cancer (father), lymphoma (maternal grandfather), no autoimmune Hx
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▪ Gen: Toxic appearing
▪ CV/Resp: Tachycardic,
tachypneic, appears in
respiratory distress
▪ Ext: LLE diffuse non-pitting
edema, erythema, ecchymosis,
& TTP

▪ CBC: WBC 17.6, Hb 10.8, PT 17.6, INR 1.5
▪ CMP: Na 119, K 6.3, Cl 87, CO2 20, BUN 42, Cr
2.23
▪ LFTs: ALBUMIN 2.7, AST 221, ALT 60, ALP 116
▪ ESR33.8, CRP 21
▪ Troponin I 29.6, CK 653, BNP 603
▪ LDH 582, Haptoglobin 294

T: 97.3 F
BP: 84/62
HR: 116
RR: 32
O2 sat: 100% on 15L NRB
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